rs 127445 has been researched along with Schizophrenia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cathala, A; Devroye, C; Drago, F; Haddjeri, N; Piazza, PV; Rovera, R; Spampinato, U; Vallée, M | 1 |
1 other study(ies) available for rs 127445 and Schizophrenia
| Article | Year |
|---|---|
Differential control of dopamine ascending pathways by serotonin2B receptor antagonists: New opportunities for the treatment of schizophrenia.
Topics: Animals; Antipsychotic Agents; Dopamine; Dopaminergic Neurons; Dose-Response Relationship, Drug; Male; Prefrontal Cortex; Pyrimidines; Rats; Rats, Sprague-Dawley; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists | 2016 |